Promacta — CareFirst (Caremark)
MYH9-related disease with thrombocytopenia
Initial criteria
- Member has thrombocytopenia associated with MYH9-related disease
Reauthorization criteria
- All members requesting continuation must continue to meet initial coverage criteria
Approval duration
12 months